Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565
Edge
ICAM2 → PIM1
Networks Including this Edge
| GSE23120_top8000 - GSE23120 - SiGN-BN NNSR | Basal gene expression data from Human Variation Panel |
| GSE3143_top8000 - GSE3143 - SiGN-BN NNSR | Breast Cancer Dataset |
| GSE10138_egf1520 - GSE10138 - SiGN-BN HC+Bootstrap | A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Duke_VA) |
| GSE10780_egf1520 - GSE10780 - SiGN-BN HC+Bootstrap | Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue |
| GSE11582_egf1520 - GSE11582 - SiGN-BN HC+Bootstrap | Genetic Analysis of Human Traits In-Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines |
| GSE14764_egf1520 - GSE14764 - SiGN-BN HC+Bootstrap | A Prognostic Gene Expression Index in Ovarian Cancer |
| GSE17705_egf1520 - GSE17705 - SiGN-BN HC+Bootstrap | Endocrine Sensitivity Index Validation Dataset |
| GSE19027_egf1520 - GSE19027 - SiGN-BN HC+Bootstrap | Antioxidant response gene expression in the bronchial airway epithelial cells of smokers at risk for lung cancer |
| GSE2034_egf1520 - GSE2034 - SiGN-BN HC+Bootstrap | Breast cancer relapse free survival |
| GSE21029_egf1520 - GSE21029 - SiGN-BN HC+Bootstrap | The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (CLL) |
| GSE23120_egf1520 - GSE23120 - SiGN-BN HC+Bootstrap | Basal gene expression data from Human Variation Panel |
| GSE26639_egf1520 - GSE26639 - SiGN-BN HC+Bootstrap | Expression Data from 226 patients of the REMAGUS02 trial |
| GSE3143_egf1520 - GSE3143 - SiGN-BN HC+Bootstrap | Breast Cancer Dataset |
| GSE31519_egf1520 - GSE31519 - SiGN-BN HC+Bootstrap | A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer |
| GSE7849_egf1520 - GSE7849 - SiGN-BN HC+Bootstrap | Age-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors |
